Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $52.25 and last traded at $52.25, with a volume of 0 shares changing hands. The stock had previously closed at $52.25.
Recordati Industria Chimica e Farmaceutica Stock Performance
The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average price of $52.05 and a 200 day moving average price of $51.76.
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. The business had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%. Research analysts forecast that Recordati Industria Chimica e Farmaceutica S.p.A. will post 2.92 EPS for the current year.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Articles
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- CD Calculator: Certificate of Deposit Calculator
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 3 Fintech Stocks With Good 2021 Prospects
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Most Volatile Stocks, What Investors Need to Know
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.